loading
60 Degrees Pharmaceuticals Inc stock is traded at $1.011, with a volume of 37,849. It is up +1.10% in the last 24 hours and down -22.23% over the past month. 60 Degrees Pharmaceuticals Inc operates as a specialty pharmaceutical company with the goal of using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. The firm's pipeline products under development cover development programs for COVID-19, fungal, tick-borne, and other viral diseases.
See More
Previous Close:
$1.00
Open:
$0.9804
24h Volume:
37,849
Relative Volume:
0.30
Market Cap:
$4.27M
Revenue:
$502.40K
Net Income/Loss:
$-7.91M
P/E Ratio:
-0.1014
EPS:
-9.972
Net Cash Flow:
$-4.32M
1W Performance:
-4.64%
1M Performance:
-22.23%
6M Performance:
-65.84%
1Y Performance:
-83.01%
1-Day Range:
Value
$0.9802
$1.02
1-Week Range:
Value
$0.9601
$1.12
52-Week Range:
Value
$0.85
$12.45

60 Degrees Pharmaceuticals Inc Stock (SXTP) Company Profile

Name
Name
60 Degrees Pharmaceuticals Inc
Name
Phone
202-327-5422
Name
Address
1025 CONNECTICUT AVENUE NW, WASHINGTON
Name
Employee
3
Name
Twitter
Name
Next Earnings Date
2025-08-15
Name
Latest SEC Filings
Name
SXTP's Discussions on Twitter

Compare SXTP with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
SXTP
60 Degrees Pharmaceuticals Inc
1.01 4.15M 502.40K -7.91M -4.32M -9.972
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
460.60 116.04B 11.74B 3.68B 3.34B 14.19
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
731.09 75.97B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
467.00 61.48B 3.21B 43.57M 221.36M 0.2405
Biotechnology icon
ARGX
Argen X Se Adr
913.29 56.40B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
205.21 43.73B 447.02M -1.18B -906.14M -6.1812

60 Degrees Pharmaceuticals Inc Stock (SXTP) Latest News

pulisher
Dec 04, 2025

Can 60 Degrees Pharmaceuticals Inc. stock maintain growth trajectoryMarket Trend Review & Daily Stock Momentum Reports - Newser

Dec 04, 2025
pulisher
Dec 03, 2025

Is 60 Degrees Pharmaceuticals Inc Equity Warrant a good long term investmentReal-Time Stock Alerts & Rapid Capital Trading Tips - earlytimes.in

Dec 03, 2025
pulisher
Nov 30, 2025

Will 60 Degrees Pharmaceuticals Inc. stock deliver long term returnsNew Guidance & Weekly Breakout Opportunity Watchlist - BỘ NỘI VỤ

Nov 30, 2025
pulisher
Nov 29, 2025

60 Degrees Pharmaceuticals (NASDAQ:SXTP) Given New $2.80 Price Target at Ascendiant Capital Markets - Defense World

Nov 29, 2025
pulisher
Nov 28, 2025

Why 60 Degrees Pharmaceuticals Inc. stock is considered a top pickLayoff News & Smart Swing Trading Alerts - BỘ NỘI VỤ

Nov 28, 2025
pulisher
Nov 28, 2025

Dick's Sporting Goods To Rally Around 17%? Here Are 10 Top Analyst Forecasts For Friday - Benzinga

Nov 28, 2025
pulisher
Nov 28, 2025

Ascendiant Capital Maintains 60 Degrees Pharmaceuticals (SXTP) Buy Recommendation - Nasdaq

Nov 28, 2025
pulisher
Nov 27, 2025

Is 60 Degrees Pharmaceuticals Inc. stock a defensive play in 20252025 Top Gainers & Capital Efficient Trading Techniques - BỘ NỘI VỤ

Nov 27, 2025
pulisher
Nov 26, 2025

How 60 Degrees Pharmaceuticals Inc. stock reacts to job market dataMarket Performance Report & Daily Stock Trend Watchlist - BỘ NỘI VỤ

Nov 26, 2025
pulisher
Nov 26, 2025

Join 60 Degrees Pharmaceuticals' Exclusive Live Investor Webinar and Q&A Session on October 22 - The Marion Star

Nov 26, 2025
pulisher
Nov 22, 2025

Enlivex Therapeutics and 60 Degrees Pharmaceuticals Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - Utica Observer Dispatch

Nov 22, 2025
pulisher
Nov 21, 2025

60 Degrees Pharmaceuticals Inc. (SXTP) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade

Nov 21, 2025
pulisher
Nov 21, 2025

60 Degrees Pharma begins enrollment for chronic babesiosis study By Investing.com - Investing.com Nigeria

Nov 21, 2025
pulisher
Nov 21, 2025

60 Degrees Pharma begins enrollment for chronic babesiosis study - Investing.com India

Nov 21, 2025
pulisher
Nov 21, 2025

60 Degrees Pharmaceuticals announces clinical site now open for patient enrollment - MarketScreener

Nov 21, 2025
pulisher
Nov 21, 2025

60 Degrees Pharmaceuticals Launches First-Ever Study for Tafenoquine in Chronic Babesiosis Patients - Quiver Quantitative

Nov 21, 2025
pulisher
Nov 21, 2025

60 Degrees Pharmaceuticals Announces Clinical Site Now Open for Patient Enrollment for the B-FREE Chronic Babesiosis Study at Mount Sinai Icahn School of Medicine - The Manila Times

Nov 21, 2025
pulisher
Nov 21, 2025

60 Degrees Pharmaceuticals Announces Clinical Site Now Open - GlobeNewswire

Nov 21, 2025
pulisher
Nov 21, 2025

Will 60 Degrees Pharmaceuticals Inc. Equity Warrant stock reach all time highs in 2025 - newser.com

Nov 21, 2025
pulisher
Nov 21, 2025

How resilient is 60 Degrees Pharmaceuticals Inc. Equity Warrant stock in market downturnsPortfolio Return Report & Low Volatility Stock Recommendations - newser.com

Nov 21, 2025
pulisher
Nov 21, 2025

Is 60 Degrees Pharmaceuticals Inc. stock supported by innovation pipeline2025 Support & Resistance & Growth Focused Stock Pick Reports - newser.com

Nov 21, 2025
pulisher
Nov 21, 2025

60 Degrees Pharmaceuticals (NASDAQ:SXTP) Upgraded at Zacks Research - Defense World

Nov 21, 2025
pulisher
Nov 20, 2025

How 60 Degrees Pharmaceuticals Inc. Equity Warrant stock performs in high volatility markets2025 Earnings Impact & Risk Controlled Daily Trade Plans - newser.com

Nov 20, 2025
pulisher
Nov 20, 2025

Will 60 Degrees Pharmaceuticals Inc. Equity Warrant see short term momentumPortfolio Update Report & High Yield Stock Recommendations - newser.com

Nov 20, 2025
pulisher
Nov 19, 2025

Can 60 Degrees Pharmaceuticals Inc. Equity Warrant stock sustain free cash flow growthJuly 2025 Short Interest & AI Enhanced Execution Alerts - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Is 60 Degrees Pharmaceuticals Inc. stock oversold or undervaluedPortfolio Risk Summary & Safe Capital Allocation Plans - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Will 60 Degrees Pharmaceuticals Inc. stock attract more institutional investors2025 Volatility Report & Expert Curated Trade Setups - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

What technical charts say about 60 Degrees Pharmaceuticals Inc. Equity Warrant stockWeekly Trade Recap & Weekly Breakout Watchlists - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Can 60 Degrees Pharmaceuticals Inc. Equity Warrant stock maintain operating margins2025 Trading Volume Trends & Safe Entry Zone Tips - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Fate Therapeutics (FATE), ALX Oncology Holdings (ALXO) and 60 Degrees Pharmaceuticals, Inc. (SXTP) - The Globe and Mail

Nov 19, 2025
pulisher
Nov 19, 2025

How to integrate 60 Degrees Pharmaceuticals Inc. Equity Warrant into portfolio analysis toolsSell Signal & AI Enhanced Trade Execution Alerts - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

60 Degrees Pharmaceuticals Faces Financial Challenges Amid Growth Efforts - MSN

Nov 19, 2025

60 Degrees Pharmaceuticals Inc Stock (SXTP) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading

60 Degrees Pharmaceuticals Inc Stock (SXTP) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
XU CHERYL
Director
Dec 13 '24
Buy
1.56
6,000
9,375
52,078
XU CHERYL
Director
Dec 12 '24
Buy
1.82
5,000
9,125
46,078
XU CHERYL
Director
Dec 16 '24
Buy
1.45
2,000
2,900
54,078
DOW GEOFFREY S
President and CEO
Dec 09 '24
Buy
1.27
35,823
45,563
94,580
DOW GEOFFREY S
President and CEO
Dec 06 '24
Buy
1.20
20,579
24,672
58,757
$39.34
price up icon 0.46%
$99.00
price down icon 1.57%
$32.09
price up icon 0.29%
$96.00
price down icon 0.08%
biotechnology ONC
$326.00
price down icon 0.32%
$205.69
price down icon 0.15%
Cap:     |  Volume (24h):